Characterising Mechanical, Chemical and Biological Removal of Interproximal Biofilms
Objectives: The build-up of bacterial biofilm (dental plaque) on tooth surfaces is the main contributor to the most common oral diseases of humans, dental caries and periodontitis. Plaque accumulates in ‘sheltered sites’ such as the subgingival margins and interproximal spaces, where it is difficult to remove. Bacterial adhesion in the mouth is somewhat hierarchical; with certain species able to adhere to the acquired enamel pellicle (early colonising bacteria); while others adhere better to established bacterial biofilms. Later colonising bacteria are more closely associated with oral disease. Devices based on combinations of air and water microdroplets have recently been introduced to remove biofilms from difficult-to-reach areas such as interproximal spaces.
The aim of this project is to further improve microdroplet-based biofilm removal by combining it with chemical or biological approaches. Methods: Biofilms of early colonising bacteria (Streptococcus gordonii, Actinomyces oris and Veillonella parvula) were cultured in an interproximal ‘Typodont’ biofilm model and challenged with the Philips Sonicare AirFloss device. A multiplex qPCR assay was developed for absolute quantification of the three species. The impact of various treatments on biofilms was also measured by cell viability assays, SEM imaging and Live:Dead staining. Results: AirFloss treatment significantly reduced adherent biofilm approximately ten-fold. By microscopy, the biofilm was almost completely removed from areas directly in the path of the Airfloss. Treatment with selected antimicrobial compounds reduced cell viability. Conclusions: Overall, these data show that the AirFloss effectively reduces biofilm biomass and indicates that chemical agents can potentially increase the impact of physical biofilm disruption. Further studies will now assess their impact on biofilm composition in more complex systems.
Division: IADR/PER General Session
Meeting:2018 IADR/PER General Session (London, England) Location: London, England
Year: 2018 Final Presentation ID:1010 Abstract Category|Abstract Category(s):Microbiology/Immunology
Authors
Jones, Rebecca
( Newcastle University
, Newcastle Upon Tyne
, United Kingdom
)
Darch, Owen
( Philips Research UK
, Cambridge
, United Kingdom
)
Jakubovics, Nicholas
( Newcastle University
, Newcastle Upon Tyne
, United Kingdom
)
Support Funding Agency/Grant Number: EPSRC, Philips Reasearch UK
Financial Interest Disclosure: This research studentship is partially funded by Philips, who own the commercial product Sonicare AirFloss which is discussed in this abstract and is the focus of this project. Philips Oral Healthcare produces a range of oral healthcare products including